Citadel Advisors’s Natural Health Trends NHTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-31,400
| Closed | -$145K | – | 15232 |
|
|
2024
Q4 | $145K | Buy |
+31,400
| New | +$170K | ﹤0.01% | 10937 |
|
|
2024
Q3 | – | Sell |
-500
| Closed | -$3.55K | – | 14895 |
|
|
2024
Q2 | $3.55K | Hold |
500
| – | – | ﹤0.01% | 13586 |
|
|
2024
Q1 | $3.35K | Buy |
500
+400
| +400% | +$2.5K | ﹤0.01% | 13915 |
|
|
2023
Q4 | $584 | Sell |
100
-3,300
| -97% | -$18.1K | ﹤0.01% | 13997 |
|
|
2023
Q3 | $18.2K | Buy |
+3,400
| New | +$18.5K | ﹤0.01% | 12693 |
|
|
2023
Q1 | – | Sell |
-2,000
| Closed | -$6.8K | – | 15220 |
|
|
2022
Q4 | $6.8K | Buy |
+2,000
| New | +$7.62K | ﹤0.01% | 13882 |
|
|
2021
Q3 | – | Sell |
-13,500
| Closed | -$94K | – | 14373 |
|
|
2021
Q2 | $94K | Buy |
+13,500
| New | +$97.6K | ﹤0.01% | 12967 |
|
|
2020
Q3 | – | Sell |
-10,700
| Closed | -$61K | – | 10516 |
|
|
2020
Q2 | $61K | Sell |
10,700
-9,900
| -48% | -$51.2K | ﹤0.01% | 9217 |
|
|
2020
Q1 | $68K | Sell |
20,600
-9,100
| -31% | -$36.9K | ﹤0.01% | 8870 |
|
|
2019
Q4 | $160K | Buy |
29,700
+16,700
| +128% | +$107K | ﹤0.01% | 8326 |
|
|
2019
Q3 | $92K | Sell |
13,000
-11,400
| -47% | -$83.6K | ﹤0.01% | 8525 |
|
|
2019
Q2 | $196K | Sell |
24,400
-15,300
| -39% | -$160K | ﹤0.01% | 8204 |
|
|
2019
Q1 | $515K | Buy |
39,700
+23,300
| +142% | +$348K | ﹤0.01% | 6742 |
|
|
2018
Q4 | $303K | Buy |
16,400
+4,900
| +43% | +$108K | ﹤0.01% | 7256 |
|
|
2018
Q3 | $268K | Sell |
11,500
-6,400
| -36% | -$157K | ﹤0.01% | 7759 |
|
|
2018
Q2 | $448K | Sell |
17,900
-2,700
| -13% | -$56.5K | ﹤0.01% | 6553 |
|
|
2018
Q1 | $392K | Buy |
20,600
+2,800
| +16% | +$47.5K | ﹤0.01% | 6294 |
|
|
2017
Q4 | $270K | Buy |
17,800
+6,100
| +52% | +$115K | ﹤0.01% | 6630 |
|
|
2017
Q3 | $280K | Sell |
11,700
-19,900
| -63% | -$454K | ﹤0.01% | 6185 |
|
|
2017
Q2 | $880K | Sell |
31,600
-700
| -2% | -$20K | ﹤0.01% | 4263 |
|
|
2017
Q1 | $933K | Buy |
32,300
+2,300
| +8% | +$61.8K | ﹤0.01% | 4109 |
|
|
2016
Q4 | $746K | Buy |
30,000
+4,100
| +16% | +$103K | ﹤0.01% | 4285 |
|
|
2016
Q3 | $732K | Buy |
25,900
+14,800
| +133% | +$459K | ﹤0.01% | 4269 |
|
|
2016
Q2 | $313K | Sell |
11,100
-9,500
| -46% | -$310K | ﹤0.01% | 5148 |
|
|
2016
Q1 | $683K | Buy |
20,600
+8,100
| +65% | +$220K | ﹤0.01% | 3982 |
|
|
2015
Q4 | $419K | Buy |
12,500
+5,200
| +71% | +$229K | ﹤0.01% | 4715 |
|
|
2015
Q3 | $239K | Sell |
7,300
-6,300
| -46% | -$191K | ﹤0.01% | 5896 |
|
|
2015
Q2 | $564K | Buy |
+13,600
| New | +$403K | ﹤0.01% | 4778 |
|
Other funds holding NHTC
VCM
VFT
BCM
Citadel Advisors's NHTC Position: Q1 2026 in Review
Citadel Advisors reduced its Natural Health Trends (NHTC) stake by 45% in Q1 2026, selling an estimated $91.8K and leaving 33,414 shares worth $93.2K. The position accounts for ﹤0.01% of the portfolio, ranked #12073.
Citadel Advisors first reported a position in NHTC in Q2 2015 and has held it in 21 quarters since. The position peaked at $704K in Q1 2019. 23 funds tracked by Wall St. Rank hold NHTC as of Q1 2026.
- Citadel Advisors held 33,414 shares of Natural Health Trends worth $93.2K as of Q1 2026.
- Citadel Advisors sold 27,457 Natural Health Trends shares in Q1 2026, an estimated $91.8K.
- Natural Health Trends made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12073 holding.
- Citadel Advisors first reported a position in Natural Health Trends in Q2 2015 and has held it in 21 quarters since.
- Citadel Advisors's Natural Health Trends position peaked at $704K in Q1 2019.
- 23 funds tracked by Wall St. Rank held Natural Health Trends as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.